Recent progress in the treatment of non-T2 asthma.
- Author:
Haiyan LONG
1
;
Jianghong WEI
2
,
3
Author Information
1. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical College, Guilin 541000, China.
2. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical College, Guilin 541000, China *Corresponding author, E-mail: weijianghong4321@
3. com.
- Publication Type:English Abstract
- MeSH:
Humans;
Asthma/therapy*;
Anti-Asthmatic Agents/therapeutic use*
- From:
Chinese Journal of Cellular and Molecular Immunology
2024;40(12):1127-1132
- CountryChina
- Language:Chinese
-
Abstract:
Non-T2 asthma, also known as non-eosinophilic asthma or low T2 asthma, does not have markers of type 2 inflammation and is often associated with hormone insensitivity and severe asthma. This article reviews the progress in drug therapy for non-T2 asthma.
